Advisory Board on Radiation and Worker Health, National Institute for Occupational Safety and Health, 80304-80305 [2023-25460]
Download as PDF
<![CDATA[
80304
Federal Register / Vol. 88, No. 221 / Friday, November 17, 2023 / Notices
FEDERAL RESERVE SYSTEM
khammond on DSKJM1Z7X2PROD with NOTICES
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in the BHC Act
(12 U.S.C. 1842(c)).
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than December 18, 2023.
A. Federal Reserve Bank of Kansas
City (Jeffrey Imgarten, Assistant Vice
President) One Memorial Drive, Kansas
City, Missouri, 64198. Comments can
also be sent electronically to:
KCapplicationcomments@kc.frb.org.
1. WDCO Ventures LLC, Oklahoma
City, Oklahoma; to become a bank
holding company by acquiring 26
percent of the voting shares of Town &
Country Bancshares, Inc., Edmond,
Oklahoma, and thereby indirectly
acquiring voting shares of Prism Bank,
Guthrie, Oklahoma.
2. Bern Bancshares, Inc., Bern,
Kansas; to acquire up to 6.83 percent of
the voting shares of UBT Bancshares,
Inc., and thereby indirectly acquire
voting shares of United Bank & Trust,
both of Marysville, Kansas.
B. Federal Reserve Bank of San
Francisco: (Joseph Cuenco, Assistant
Vice President, Formations,
Transactions & Enforcement) 101
Market Street, San Francisco, California
VerDate Sep<11>2014
18:57 Nov 16, 2023
Jkt 262001
94105. Comments can also be sent
electronically to:
sf.fisc.comments.applications@
sf.frb.org.
1. PCB Financial, Inc., Costa Mesa,
California; to become a bank holding
company by acquiring Northern
California Bancorp, Inc., and thereby
indirectly acquiring Monterey County
Bank, both of Monterey, California.
Board of Governors of the Federal Reserve
System.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2023–25462 Filed 11–16–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health, National Institute for
Occupational Safety and Health
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with regulatory
provisions, the Centers for Disease
Control and Prevention (CDC)
announces a meeting of the Advisory
Board on Radiation and Worker Health
(ABRWH or the Advisory Board). This
meeting is open to the public, with a
public comment period. The public is
welcome to submit written comments in
advance of the meeting, to the contact
person below. Written comments
received in advance of the meeting will
be included in the official record of the
meeting. The public is also welcomed to
listen to the meeting by joining the
teleconference (information below). The
audio conference line has 150 ports for
callers.
DATES: The meeting will be held on
December 7, 2023 from 11 a.m. to 6 p.m.
EST. A public comment session will be
held at 5 p.m. and will conclude at 6
p.m. or following the final call for
public comment, whichever comes first.
Written comments must be received on
or before November 30, 2023.
ADDRESSES: You may submit comments
by mail to: Rashaun Roberts, National
Institute for Occupational Safety and
Health, 1090 Tusculum Avenue, MS C–
24, Cincinnati, Ohio 45226.
Meeting Information: The USA tollfree dial-in numbers are: +1 669 254
5252 US (San Jose); +1 646 828 7666 US
(New York). The Meeting ID is: 160
SUMMARY:
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
6763 3819 and the Passcode is:
98685439; Web conference by Zoom
meeting connection: https://
cdc.zoomgov.com/j/16067633819?
pwd=RUdiYXlZZHFKanpJOHZrcGJIb
TlaZz09.
FOR FURTHER INFORMATION CONTACT:
Rashaun Roberts, Ph.D., Designated
Federal Officer, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
1090 Tusculum Avenue, Mailstop C–24,
Cincinnati, Ohio 45226, Telephone
(513) 533–6800, Toll Free 1(800) CDC–
INFO, Email: ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC). In
December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS,
which subsequently delegated this
authority to the Centers for Disease
Control and Prevention (CDC). The
National Institute for Occupational
Safety and Health implements this
responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
and rechartered under Executive Order
13889 on March 22, 2022, and will
terminate on March 22, 2024.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
E:\FR\FM\17NON1.SGM
17NON1
Federal Register / Vol. 88, No. 221 / Friday, November 17, 2023 / Notices
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters To Be Considered: The agenda
will include discussions on the
following: NIOSH Program Update;
Department of Labor (DOL) Program
Update; Department of Energy (DOE)
Program Update; Special Exposure
Cohort (SEC) Petitions Update;
Background and Update on
Subcommittee for Procedures Review
Activities; Pinellas Workgroup Update,
Metals and Control Workgroup Update,
Dose Reconstruction Review Methods
Workgroup Update, and a Board Work
Session. Agenda items are subject to
change as priorities dictate.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2023–25460 Filed 11–16–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Injury Prevention
and Control
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of closed meeting.
AGENCY:
In accordance with regulatory
provisions, the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
Board of Scientific Counselors, National
Center for Injury Prevention and Control
(BSC, NCIPC or Board). This meeting is
partially open to the public.
DATES: The meeting will be held on
January 11, 2024. The first session of the
day will be held from 10 a.m. to 12:05
p.m., EST (OPEN), and the second
session will be held from 1 p.m. to 4:30
p.m., EST (CLOSED). The public
comment period will be at the end of
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:57 Nov 16, 2023
Jkt 262001
the open session of the meeting, from
11:45 a.m. to 12:00 p.m., EST.
ADDRESSES: Webinar, Atlanta, Georgia.
All participants must register by using
the following link to attend the open
session: https://cdc.zoomgov.com/
meeting/register/vJItf-igpjopGsXuGU
hsdlIOmRCB2yx509k.
FOR FURTHER INFORMATION CONTACT:
Christopher R. Harper, Ph.D.,
Designated Federal Officer, Board of
Scientific Counselors, National Center
for Injury Prevention and Control,
Centers for Disease Control and
Prevention, 4770 Buford Highway NE,
Mailstop S–1069, Atlanta, Georgia
30341. Telephone: (404) 718–8330;
Email: ncipcbsc@cdc.gov.
SUPPLEMENTARY INFORMATION: Portions
of the meeting referenced above will be
closed to the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5, U.S.C., and
the Determination of the Director, Office
of Strategic Business Initiatives, Office
of the Chief Operating Officer, Centers
for Disease Control and Prevention,
pursuant to 5 U.S.C. 1009 (Pub. L. 92–
463, as amended).
Purpose: The Board of Scientific
Counselors, National Center for Injury
Prevention and Control (BSC, NCIPC or
Board) will: (1) conduct, encourage,
cooperate with, and assist other
appropriate public health authorities,
scientific institutions, and scientists in
the conduct of research, investigations,
experiments, demonstrations, and
studies relating to the causes and
strategies related to the prevention of
injury, overdose, and violence; (2) assist
States and other entities in preventing
intentional and unintentional injuries,
and to promote health and well-being;
and (3) make recommendations of grants
and cooperative agreements for research
and prevention activities related to
injury, overdose, and violence. The
BSC, NCIPC makes recommendations
regarding policies, strategies, objectives,
and priorities and reviews progress
toward injury, overdose, and violence
prevention. The Board also provides
advice on the appropriate balance of
intramural and extramural research and
provides guidance on the needs,
structure, progress, and performance of
intramural programs. Further, the Board
provides guidance on extramural
scientific program matters.
Additionally, the Board provides
second-level scientific and
programmatic review of applications for
research grants, cooperative agreements,
and training grants related to injury,
overdose, and violence prevention, and
recommends approval of projects that
merit further consideration for funding
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
80305
support. The Board also provides
feedback and input on strategic plans,
resources, and priority publications
related to injury, overdose, and violence
prevention.
Matters To Be Considered: The open
session of the meeting will include a
discussion on the updated Intimate
Partner Violence Research Priorities.
The closed session of the meeting will
focus on the secondary peer review of
extramural research grant applications
received in response to one (1) Notice of
Funding Opportunity: RFA–CE–24–
001—‘‘Grants for Injury Control
Research Centers.’’ Agenda items are
subject to change as priorities dictate.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2023–25456 Filed 11–16–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2023–N–4807]
General Hospital and Personal Use
Devices Panel of the Medical Devices
Advisory Committee; Notice of
Meeting; Establishment of a Public
Docket; Request for Comments—506J
Device List
AGENCY:
Food and Drug Administration,
HHS.
Notice; establishment of a
public docket; request for comments.
ACTION:
The Food and Drug
Administration (FDA) announces a
forthcoming public advisory committee
meeting of the General Hospital and
Personal Use Devices Panel of the
Medical Devices Advisory Committee
(the Committee). The general function of
the Committee is to provide advice and
recommendations to FDA on regulatory
issues. The meeting will be open to the
public. FDA is establishing a docket for
public comment on this document.
SUMMARY:
E:\FR\FM\17NON1.SGM
17NON1
]]>Agencies
[Federal Register Volume 88, Number 221 (Friday, November 17, 2023)]
[Notices]
[Pages 80304-80305]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-25460]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health, National Institute
for Occupational Safety and Health
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with regulatory provisions, the Centers for
Disease Control and Prevention (CDC) announces a meeting of the
Advisory Board on Radiation and Worker Health (ABRWH or the Advisory
Board). This meeting is open to the public, with a public comment
period. The public is welcome to submit written comments in advance of
the meeting, to the contact person below. Written comments received in
advance of the meeting will be included in the official record of the
meeting. The public is also welcomed to listen to the meeting by
joining the teleconference (information below). The audio conference
line has 150 ports for callers.
DATES: The meeting will be held on December 7, 2023 from 11 a.m. to 6
p.m. EST. A public comment session will be held at 5 p.m. and will
conclude at 6 p.m. or following the final call for public comment,
whichever comes first. Written comments must be received on or before
November 30, 2023.
ADDRESSES: You may submit comments by mail to: Rashaun Roberts,
National Institute for Occupational Safety and Health, 1090 Tusculum
Avenue, MS C-24, Cincinnati, Ohio 45226.
Meeting Information: The USA toll-free dial-in numbers are: +1 669
254 5252 US (San Jose); +1 646 828 7666 US (New York). The Meeting ID
is: 160 6763 3819 and the Passcode is: 98685439; Web conference by Zoom
meeting connection: https://cdc.zoomgov.com/j/16067633819?pwd=RUdiYXlZZHFKanpJOHZrcGJIbTlaZz09.
FOR FURTHER INFORMATION CONTACT: Rashaun Roberts, Ph.D., Designated
Federal Officer, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention, 1090 Tusculum Avenue,
Mailstop C-24, Cincinnati, Ohio 45226, Telephone (513) 533-6800, Toll
Free 1(800) CDC-INFO, Email: [email protected].
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines which have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule, advice on methods of dose reconstruction which have
also been promulgated by HHS as a final rule, advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program, and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC). In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the Centers for Disease
Control and Prevention (CDC). The National Institute for Occupational
Safety and Health implements this responsibility for CDC.
The charter was issued on August 3, 2001, renewed at appropriate
intervals, and rechartered under Executive Order 13889 on March 22,
2022, and will terminate on March 22, 2024.
Purpose: This Advisory Board is charged with (a) providing advice
to the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advising the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is
[[Page 80305]]
reasonable likelihood that such radiation doses may have endangered the
health of members of this class.
Matters To Be Considered: The agenda will include discussions on
the following: NIOSH Program Update; Department of Labor (DOL) Program
Update; Department of Energy (DOE) Program Update; Special Exposure
Cohort (SEC) Petitions Update; Background and Update on Subcommittee
for Procedures Review Activities; Pinellas Workgroup Update, Metals and
Control Workgroup Update, Dose Reconstruction Review Methods Workgroup
Update, and a Board Work Session. Agenda items are subject to change as
priorities dictate.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-25460 Filed 11-16-23; 8:45 am]
BILLING CODE 4163-18-P
